DILIC
VRTX icon

Dai-ichi Life Insurance Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.33M Sell
14,165
-373
-3% -$174K 0.18% 122
2025
Q4 		$6.59M Buy
14,538
+2,400
+20% +$1.03M 0.17% 120
2025
Q3 		$4.75M Sell
12,138
-12,898
-52% -$5.39M 0.12% 165
2025
Q2 		$11.1M Sell
25,036
-5,965
-19% -$2.75M 0.31% 76
2025
Q1 		$15M Sell
31,001
-923
-3% -$430K 0.44% 59
2024
Q4 		$12.9M Buy
31,924
+5,831
+22% +$2.7M 0.36% 64
2024
Q3 		$12.1M Sell
26,093
-4,219
-14% -$2.03M 0.31% 77
2024
Q2 		$14.2M Sell
30,312
-24,362
-45% -$10.6M 0.35% 75
2024
Q1 		$22.9M Sell
54,674
-17,546
-24% -$7.42M 0.52% 42
2023
Q4 		$29.4M Buy
72,220
+11,394
+19% +$4.21M 0.61% 35
2023
Q3 		$21.2M Hold
60,826
– – 0.47% 45
2023
Q2 		$21.4M Sell
60,826
-130
-0.2% -$43.8K 0.45% 50
2023
Q1 		$19.2M Buy
60,956
+8,362
+16% +$2.51M 0.42% 50
2022
Q4 		$15.2M Hold
52,594
– – 0.35% 56
2022
Q3 		$15.2M Sell
52,594
-260
-0.5% -$74.8K 0.38% 55
2022
Q2 		$14.9M Sell
52,854
-49,593
-48% -$13.3M 0.33% 62
2022
Q1 		$26.7M Buy
102,447
+43
+0% +$10.2K 0.43% 54
2021
Q4 		$22.5M Sell
102,404
-18,000
-15% -$3.5M 0.29% 71
2021
Q3 		$21.8M Buy
120,404
+4,057
+3% +$792K 0.28% 68
2021
Q2 		$23.5M Buy
116,347
+30,000
+35% +$6.28M 0.29% 64
2021
Q1 		$18.6M Sell
86,347
-5,493
-6% -$1.21M 0.26% 64
2020
Q4 		$21.7M Buy
91,840
+27,623
+43% +$6.34M 0.31% 53
2020
Q3 		$17.5M Buy
64,217
+8,726
+16% +$2.41M 0.31% 59
2020
Q2 		$16.1M Buy
55,491
+33,965
+158% +$9.21M 0.37% 52
2020
Q1 		$5.12M Buy
21,526
+1,359
+7% +$312K 0.2% 123
2019
Q4 		$4.42M Buy
20,167
+41
+0.2% +$8.3K 0.1% 204
2019
Q3 		$3.41M Hold
20,126
– – 0.08% 242
2019
Q2 		$3.69M Hold
20,126
– – 0.09% 222
2019
Q1 		$3.7M Hold
20,126
– – 0.09% 225
2018
Q4 		$3.33M Sell
20,126
-19
-0.1% -$3.29K 0.09% 226
2018
Q3 		$3.88M Sell
20,145
-52,894
-72% -$9.42M 0.08% 226
2018
Q2 		$12.4M Buy
73,039
+36,363
+99% +$5.64M 0.3% 80
2018
Q1 		$5.98M Buy
36,676
+7,251
+25% +$1.18M 0.12% 163
2017
Q4 		$4.41M Sell
29,425
-442
-1% -$65.4K 0.09% 201
2017
Q3 		$4.54M Buy
29,867
+906
+3% +$136K 0.1% 201
2017
Q2 		$3.73M Buy
28,961
+17,576
+154% +$2.12M 0.08% 222
2017
Q1 		$1.25M Sell
11,385
-15,000
-57% -$1.32M 0.03% 354
2016
Q4 		$1.94M Buy
+26,385
New +$2.15M 0.06% 301

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dai-ichi Life Insurance Company's VRTX Position: Q1 2026 in Review

Dai-ichi Life Insurance Company reduced its Vertex Pharmaceuticals (VRTX) stake by 2.6% in Q1 2026, selling an estimated $174K and leaving 14,165 shares worth $6.33M. The position accounts for 0.18% of the portfolio, ranked #122.

Dai-ichi Life Insurance Company first reported a position in VRTX in Q4 2016 and has held it in 38 quarters since. The position peaked at $29.4M in Q4 2023. 1,690 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Dai-ichi Life Insurance Company held 14,165 shares of Vertex Pharmaceuticals worth $6.33M as of Q1 2026.
  • Dai-ichi Life Insurance Company sold 373 Vertex Pharmaceuticals shares in Q1 2026, an estimated $174K.
  • Vertex Pharmaceuticals made up 0.18% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #122 holding.
  • Dai-ichi Life Insurance Company first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 38 quarters since.
  • Dai-ichi Life Insurance Company's Vertex Pharmaceuticals position peaked at $29.4M in Q4 2023.
  • 1,690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.